SIRT7 and neoplasm: The histone deacylase sirtuin 7 (SIRT7) has recently been recognized to play complex, context-dependent roles in tumor initiation and progression by controlling tumor-intrinsic and tumor-extrinsic mechanisms, making it a molecule of growing interest and a promising target for the development of anti-cancer therapies [1].